Gilead Sciences, Inc. (BIT:1GILD)
131.38
+5.32 (4.22%)
At close: Feb 11, 2026
Gilead Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7,564 | 9,991 | 6,085 | 5,412 | 5,338 |
Short-Term Investments | 3,041 | 1,577 | 2,265 | 1,446 | 2,067 |
Cash & Short-Term Investments | 10,605 | 11,568 | 8,350 | 6,858 | 7,405 |
Cash Growth | -8.33% | 38.54% | 21.76% | -7.39% | -16.08% |
Accounts Receivable | 4,913 | 4,420 | 4,660 | 4,777 | 4,493 |
Receivables | 4,913 | 4,420 | 4,660 | 4,777 | 4,493 |
Inventory | 4,368 | 1,710 | 1,787 | 1,507 | 1,618 |
Prepaid Expenses | - | 480 | 559 | 1,241 | 1,181 |
Other Current Assets | - | 995 | 729 | 60 | 75 |
Total Current Assets | 19,886 | 19,173 | 16,085 | 14,443 | 14,772 |
Property, Plant & Equipment | 5,606 | 5,929 | 5,898 | 5,980 | 5,663 |
Long-Term Investments | - | 327 | 1,819 | 2,611 | 2,844 |
Goodwill | 8,314 | 8,314 | 8,314 | 8,314 | 8,332 |
Other Intangible Assets | 16,978 | 19,948 | 26,454 | 28,894 | 33,455 |
Other Long-Term Assets | 8,239 | 5,304 | 3,555 | 2,929 | 2,886 |
Total Assets | 59,023 | 58,995 | 62,125 | 63,171 | 67,952 |
Accounts Payable | - | 833 | 550 | 905 | 705 |
Accrued Expenses | - | 5,120 | 5,003 | 4,497 | 6,996 |
Current Portion of Long-Term Debt | - | 1,815 | 1,798 | 2,273 | 1,516 |
Current Portion of Leases | - | 113 | 125 | 111 | 101 |
Current Income Taxes Payable | - | 1,646 | 1,208 | 959 | 539 |
Other Current Liabilities | 11,813 | 2,477 | 2,596 | 2,492 | 1,753 |
Total Current Liabilities | 11,813 | 12,004 | 11,280 | 11,237 | 11,610 |
Long-Term Debt | 24,592 | 24,896 | 23,189 | 22,957 | 25,179 |
Long-Term Leases | - | 498 | 546 | 467 | 489 |
Long-Term Deferred Tax Liabilities | - | 724 | 1,588 | 2,673 | 4,356 |
Other Long-Term Liabilities | - | 1,627 | 2,773 | 4,628 | 5,254 |
Total Liabilities | 36,405 | 39,749 | 39,376 | 41,962 | 46,888 |
Common Stock | 22,618 | 1 | 1 | 1 | 1 |
Additional Paid-In Capital | - | 7,700 | 6,500 | 5,550 | 4,661 |
Retained Earnings | - | 11,497 | 16,304 | 15,687 | 16,324 |
Comprehensive Income & Other | - | 132 | 28 | 2 | 83 |
Total Common Equity | 22,618 | 19,330 | 22,833 | 21,240 | 21,069 |
Minority Interest | - | -84 | -84 | -31 | -5 |
Shareholders' Equity | 22,618 | 19,246 | 22,749 | 21,209 | 21,064 |
Total Liabilities & Equity | 59,023 | 58,995 | 62,125 | 63,171 | 67,952 |
Total Debt | 24,592 | 27,322 | 25,658 | 25,808 | 27,285 |
Net Cash (Debt) | -13,987 | -15,754 | -16,145 | -17,705 | -18,571 |
Net Cash Per Share | -11.15 | -12.55 | -12.83 | -14.03 | -14.72 |
Filing Date Shares Outstanding | 1,241 | 1,245 | 1,246 | 1,247 | 1,254 |
Total Common Shares Outstanding | 1,241 | 1,246 | 1,246 | 1,247 | 1,254 |
Working Capital | 8,073 | 7,169 | 4,805 | 3,206 | 3,162 |
Book Value Per Share | 18.23 | 15.51 | 18.33 | 17.03 | 16.80 |
Tangible Book Value | -2,674 | -8,932 | -11,935 | -15,968 | -20,718 |
Tangible Book Value Per Share | -2.15 | -7.17 | -9.58 | -12.81 | -16.52 |
Land | - | 561 | 561 | 562 | 404 |
Buildings | - | 4,540 | 4,328 | 4,390 | 3,794 |
Machinery | - | 2,282 | 2,216 | 1,990 | 1,759 |
Construction In Progress | - | 501 | 661 | 719 | 1,057 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.